Résumé
Vaccination in pregnancy (VIP) is dually beneficial – it protects the mother and the baby from tetanus, influenza, and pertussis. VIP uptake is low in many countries. Vaccine hesitancy, defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccination despite the availability of vaccination services” is one of WHO's ten threats to global health per 2019. According to extensive research, mostly from high-income countries (HIC) and limited to tetanus, influenza and pertussis vaccines, lack of provider recommendations, safety concerns, and limitations in access are the main barriers to VIP. Health care provider recommendation is the leading facilitator for VIP across various socioeconomic status groups. Data on strategies to overcome patient, provider, and system barriers to VIP are inconsistent, contradictory, or lacking. Patient-focused research on evidence-based strategies to overcome provider and system barriers is needed. Furthermore, VIP programs require embedded continuous quality improvement to ensure sustainability.
| Langue d'origine | English |
|---|---|
| Pages (de-à) | 83-95 |
| Nombre de pages | 13 |
| Journal | Best Practice and Research in Clinical Obstetrics and Gynaecology |
| Volume | 76 |
| DOI | |
| Statut de publication | Published - oct. 2021 |
Note bibliographique
Funding Information:People and sources of funding: Funding support was provided by the University of Calgary Academic Alternate Relationship Plan.
Publisher Copyright:
© 2021
ASJC Scopus Subject Areas
- Obstetrics and Gynaecology
PubMed: MeSH publication types
- Journal Article
- Review
ODD de l’ONU
Cette action contribue à la réalisation des objectifs de développement durable suivants
